The clinical trials below are available in the specialty you selected. Choose a different specialty.
Development of Prognostic Platelet RNA Biomarkers to Tailor Antiplatelet Therapy
Healthy volunteers and people with Type 2 Diabetes are needed to participate in an aspirin research study at the Duke Clinical Research Unit. The study will evaluate the effect of aspirin and ticagrelor (an antiplatelet agent similar to aspirin) on the genomic profiles of whole blood and platelets.
Study participation will involve 5 or 6 visits to the DCRU over the course of approximately 5 months. The aspirin & ticagrelor therapy for participants will last 16 weeks. Financial compensation is provided for participation. (REF# 00048621)
Smoking Asthmatics Research Study
Asthma patients who also smoke are needed to take part in a research study at the Duke Clinical Research Unit. The study will examine whether questionnaires used to evaluate asthma symptoms in non-smokers can also be applied to people with asthma who smoke. Participation will require 2 clinic visits that are approximately 6 weeks apart. (REF# 41549)
Asthma Patient Registry
The Duke Clinical Research Unit is enrolling people with asthma into the American Lung Association's Asthma Clinical Research Center patient registry. (REF# 18719)
Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients with Asthma
Asthma patients who do not smoke and have been using medication for at least a year are needed to take part in a research study at the Duke Clinical Research Unit. (REF# 34572)
Long-Acting Beta Agonist Step Down Study (LASST)
Males and females, age 12 years and older are needed to participate in a research study to evaluate the optimal treatment strategy for reducing therapy in people with asthma. (REF# Pro00034544)